Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells-Reference-Cited by-同舟云学术

Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells

Published:2020-09 Issue: Volume:882 Page:173298
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Momeny Majid,Sankanian Ghazaleh,Hamzehlou Sepideh,Yousefi Hassan,Esmaeili Fatemeh,Alishahi Zivar,Karimi Behnaz,Zandi Zahra,Shamsaiegahkani Sahar,Sabourinejad Zahra,Kashani Bahareh,Nasrollahzadeh Ali,Mousavipak Seyyedeh H.,Mousavi Seyed A.,Ghaffari Seyed H.

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Elsevier BV

Subject

Pharmacology

Reference78 articles.

1. Apoptosis-modulating agents in combination with radiotherapy—current status and outlook;Belka;Int. J. Radiat. Oncol. Biol. Phys.,2004

2. EMT in cancer;Brabletz;Nat. Rev. Canc.,2018

3. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Bubendorf;Hum. Pathol.,2000

4. Issues and promises of bevacizumab in prostate cancer treatment;Cereda;Expet Opin. Biol. Ther.,2018

5. Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer;Dahut;BJU Int.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A patent perspective of antiangiogenic agents;Expert Opinion on Therapeutic Patents;2023-12-02

2. Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions;BioChem;2023-08-29

3. A Systematic Review and Meta-Analysis: Safety and Efficacy of Cediranib in the Treatment of Cancer Patients;Journal of Clinical Pharmacy and Therapeutics;2023-08-22

4. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

5. LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-05-25